he received from a doctor in 2008 on the clinical trial of an Alzheimer's disease drug to make profits and avoid losses for SAC in an amount totaling approximately USD 276 million.
According to allegations in the three-count criminal complaint, Martoma exploited his personal and financial relations with a leading doctor who chaired the Safety Monitoring Committee (SMC) for the trial.
Martoma obtained inside information about the drug trial that the doctor Sidney Gilman learned at the SMC meetings and through other communications with drug companies Elan and Wyeth.
Bharara has led the government's massive crackdown on insider trading and won convictions against prominent Wall Street executives like ex-Goldman director Rajat Gupta and billionaire hedge fund founder Raj Rajaratnam.
Since October 2009, 78 people have either pleaded guilty or been convicted on insider trading charges.
The trial comes close on the heels of last month's insider trading conviction of another SAC employee, Michael Steinberg, and SAC's guilty plea in November to insider trading charges.